ASX slips; Bapcor tanks and Fortescue hits record
The ASX wobbled as Tesla stalled and Bapcor crashed, while Fortescue surged and Northern Star ditched its gold hedge.
The ASX wobbled as Tesla stalled and Bapcor crashed, while Fortescue surged and Northern Star ditched its gold hedge.
The pace of the quarterly reporting is picking up, with several up-and-coming biotechs revealing record performances.
Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.
Former RHC Australia CEO and EMVision’s newest board director Carmel Monaghan believes the company’s early stroke-detection tech has huge potential.
After a long winter, lithium has begun to claw its way back this month. Is this a dead cat bounce, or something more?
Odyssey Gold could be screaming value as it kicks off technical studies on its 407,000oz Tuckanarra gold project in WA’s Murchison.
Uranium equities at the small end of the market are primed for a re-rate, on the back of a revival in the U3O8 spot price.
A definitive feasibility study update has drastically improved financials for West Wits Mining’s Qala Shallows gold project in South Africa.
The ASX has added 0.69pc in a solid day of trading with 11 of 10 sectors in the green. Resources stocks led gains once again.
The ASX rode the iron ore train higher thanks to China’s dam dreams, but Telix blew a tyre on SEC drama.
The US Securities and Exchange Commission (SEC) has subpoenaed information from Telix, in relation to the company’s prostate cancer therapeutic program.
Mayur Resources will rebrand as Pacific Lime and Cement to reflect its focus on supplying those materials in a nation-building PNG project.
The ASX 200 has started the day in the green on another uptick in gold prices, driving the gold index up more than 2pc.
Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.
While conditions remain patchy, Sydney and Brisbane are leading the office sector recovery and Melbourne is recovering from its funk.
Big Tech earnings are landing just as JPMorgan warns markets are dangerously crowded with not much fuel left to push higher.
While ASX medicinal cannabis stocks have largely failed to bud, some are lighting the way with differentiated strategies.
VR8 lead the way on Tuesday after signing an offtake deal for vanadium-rich magnetite DSO from the Steelpoortdrift project in South Africa.
The ASX has finished a tumultuous day of trade by edging into positive territory, as gold and iron ore stocks provide much needed support.
The market’s choppy but ASX miners have rallied on Tuesday on iron ore gains. Meanwhile, Insignia’s soared on a $3.3bn buyout.
Original URL: https://www.news.com.au/finance/business/stockhead/page/3